|
Small
and micro cap funds require
fund managers to be risk takers
and cautious at the same time.
Historically, this universe
of stocks is not well covered
or researched by Wall Street
brokers, and investors do
not have enough timely information
regarding these companies.
The Oppenheimer Emerging Growth
fund is one of the unique
funds that seek emerging growth
in all the right places.
Q:
The
Micro and Small Cap universe
is not well known to investors.
What is your investment philosophy
for this market sector?
A:
The micro and small
cap universe, which comprises
less than ten percent in market
capitalization, has more than
seventy percent of the listed
stocks on various exchanges.
The opportunity to invest
in this sector can be rewarding
to those investors who are
willing to research the companies,
understand the stock volatility
and have the discipline to
be a long-term investor. We
screen thousands of stocks
and select around one hundred
for the portfolio. Our investment
philosophy centers on identifying
new product cycles that drive
revenue and earnings growth,
which in turn drives share
price performance.
-----------------------------------------------------------------------------------
Q:
What
is your investment strategy
to find these stocks?
A:
As an emerging growth
fund seeking to invest in
micro and small cap growth
stocks, we focus on companies
that have a market cap below
$1.5 billion. We try not to
buy illiquid stocks whose
average daily trading volume
is less than 100,000 shares.
We are not averse to buying
micro-cap stocks as long as
the trading volumes for the
stock meet our criteria. We
also look for companies that
have proprietary products
or services and have the potential
to emerge as leaders in their
field.
We look
for companies with projected
profitability, although we
pay attention to historical
earnings. We often find the
inflection point in earnings
from loss to profitability
to be an attractive indicator,
however we will not buy companies
that are not expected to be
profitable in the next three
years. We use consensus earnings
projections when available
and aggregate those models
to create our own proprietary
revenue and earnings models.
Maybe ten to fifteen percent
of the portfolio's stocks
are not covered by anyone
on the street while a much
larger percentage of stocks
we own are covered by only
one or two analysts.
-----------------------------------------------------------------------------------
Q:
Is
the information advantage
real in this sector?
A:
I would say the answer is
yes. We try to find companies
that are relatively under-followed.
While many of these companies
have growing revenue and earnings;
the brokerage community is
simply not monitoring these
companies closely. We find
that they tend to have lower
debt and less complicated
balance sheets and if you
have a systematic way to monitor
these companies you can find
attractive investments.
-----------------------------------------------------------------------------------
Q: What
kinds of investment screens
do you use and what kinds
of companies pass your muster?
A:
We start with a universe
of U.S.-traded companies with
market capitalizations of
less than $1.5 billion. Using
proprietary screening techniques,
we sift among these thousands
of companies to identify the
200 to 250 candidates that
best meet our investment criteria.
We then subject these candidates
to intensive fundamental research
- the foundation of our process.
In addition to inspecting
each company's operating history,
we personally visit every
company we can, talking to
management teams to thoroughly
understand their business
philosophy and practices,
competitive position and prospects
for future growth. Finally,
we confirm our judgments through
a process of technical analysis
that helps us evaluate stock
price movements and pinpoint
attractive buying opportunities.
We generally continue to hold
a stock unless a company's
business fundamentals change
or the stock appreciates more
quickly than we believe is
justified by the company's
growth rate.
-----------------------------------------------------------------------------------
Q:
Do
you like to meet management?
A:
In our experience we have
found it essential to meet
company management. I have
three analysts on my team
and we try to meet as many
companies as we can, sometimes
as many as 20 companies a
week. We try to understand
what is proprietary about
these companies' products
and services that will allow
them to emerge as a leader.
These meetings prove very
useful in helping us to not
only understand the company's
long-term vision, but also
their competitive environment.
We like to form an opinion
whether management has the
capability to generate higher
revenue and earnings and steer
the company to the next level.
We think we can only do that
by meeting them and understanding
their long-term growth strategies.
-----------------------------------------------------------------------------------
Q:
Do
you use technical analysis
to your advantage?
A:
Absolutely. Once our quantitative
screening process and fundamental
research is completed, we
then conduct technical analysis
as our final confirmation
to pinpointing attractive
buying and selling opportunities.
The reason we use technical
analysis is because the stocks
in the micro and small-cap
sector can be very volatile
and we want to capture that
volatility in trading. Additionally,
we use moving averages and
money flows coupled with trend
and support lines to figure
out the best entry and exit
point in stocks.
-----------------------------------------------------------------------------------
Q:
Why
do you have a high portfolio
turnover ratio?
A:
The official portfolio turnover
ratio is approximately 200%.
The reason that the turnover
is so high is because we try
to trade in and around stock
positions, trying to add value
by capturing volatility. For
example, for the last eighteen
months, we have owned a company
called eResearch Technology
Inc. The stock has traded
between $17 and $34 and currently
resides around $25. Because
our trading strategy takes
advantage of this type of
volatility, we generally generate
a higher turnover ratio, and
not because of selling the
entire position of a stock.
-----------------------------------------------------------------------------------
Q:
What
is your sell discipline?
A:
First, we look to see if there
are any changes in the fundamental
outlook for the company, second
we monitor valuations. If
a stock is trading at twice
the one-year growth rate,
then it is a sell candidate.
Additionally, if we buy a
stock and it declines 15%
from the purchase price, we
sell. However, if the sector
is also down, then we may
not sell the stock. We also
look for warning signs such
as insider selling or when
a stock declines due to large
volume activity or any major
change in the growth rate
of the company. From the portfolio
perspective, we may sell stocks
if any one sector or security
becomes too overweight.
-----------------------------------------------------------------------------------
Q:
Does
the fund track any index?
A:
We do not manage this
fund to track an index. We
are benchmark sensitive when
it comes to industry and sector
allocations. Additionally,
we are conscious of portfolio
factors such as market cap,
P/E and beta relative to our
benchmark.
“We look
for companies that have projected
profitability. We pay greater
attention historical earnings.
The inflection point in the
earnings from a loss to the
profitability is attractive
to us.”
| about:
Laura E. Granger
Laura Granger is a Vice
President and Portfolio
Manager responsible
for the Oppenheimer
Emerging Growth Fund,
which launched in November
2000. Additionally,
since July 2002, she
has managed the Oppenheimer
Emerging Technologies
Fund, and since March
2003, she has managed
the Oppenheimer Discovery
Fund. Ms. Granger is
a member of the Equity
department's Growth
Investment team.
Before joining OppenheimerFunds
in October 2000, she
was a Vice President
and Portfolio Manager
at Fortis Advisors,
where she managed the
Fortis Capital Appreciation
and the Fortis Aggressive
Series Growth Funds.
Prior to Fortis, she
managed pension and
foundation accounts
for General Motors Investment
Management.
Ms. Granger is a graduate
of Cornell University
and is a Chartered Financial
Analyst. She has 19
years of industry experience,
including 12 years as
an investment manager.
During her career, Ms.
Granger has been featured
in financial publications
such as The Wall Street
Journal and Investor's
Business Daily. |
Q:
What
are your parameters for the
portfolio construction?
A:
The portfolio is broadly diversified
and built from a bottom-up
stock picking perspective.
We do not own any stock with
a weighting greater than 2.5%
of the fund. Because our universe
is so volatile, we do not
want too few specific stocks
to impact the fund. This fact
differentiates us from many
of our competitors that have
significantly higher weightings
in stocks. For example, some
of our peers hold 5% to 8%
positions in single stocks
in their funds. We do not
make those types of big bets.
-----------------------------------------------------------------------------------
Q:
Can
we discuss some of your winners
and losers?
A:
We tend to find many opportunities
in the tech, healthcare and
consumer sectors that meet
our disciplined criteria.
eResearch
Technology Inc is a great
example of one of our winners.
Our investment screens flagged
the company's growing revenue
and earnings and we met the
company's management team.
The company has a proprietary
technology solution that allows
pharmaceutical, biotech and
medical device companies to
digitize clinical trial data
that gets filed with the FDA.
The FDA has recently requested
companies to submit clinical
trial data in this format.
eResearch is one of a few
companies that enable users
to digitize data for filing.
They have signed several contracts
with major pharmaceutical
companies. This is a good
example of the kind of stock
that we like to own as it
has strong management and
a proprietary technology.
From the time we initially
purchased the stock, earnings
estimates have quadrupled.
Over the
course of the year Martek
Biosciences (MATK) was among
the largest contributors to
the Fund's performance. The
company develops two nutritional
fatty acids (DHA & ARA)
that are sold to infant formula
manufacturers. These fatty
acids, when added to infant
formulas are important for
proper brain and eye development
and have been proven to increase
IQ in studies. They have also
been shown to support cardiovascular
health in adults. The company
has a proprietary technology
that derives these fatty acids
from microalgae. Typically
these are derived from fish
oils, and since many fish
are contaminated with mercury
and other carcinogens, they
may be a risk to developing
infants. The company is experiencing
triple digit growth rates.
The investment was a success
and the company met all the
criteria that we have in stock
selection such as a proprietary
technology, a new product
cycle, strong management and
extremely strong operating
fundamentals. The stock was
initially not well covered
by Wall Street analysts but
seems to have been discovered
more recently as more firms
picked up coverage.
Not all
our picks work out. United
Online is one such stock.
The company through its subsidiaries
NetZero, Juno and BlueLight
provide free and value-priced
Internet access and email
over speed-band accelerated
dial up services. While the
company has had strong subscriber
gains, record profits, and
has increased earnings guidance
it has been under a negative
cloud since AOL announced
they would provide a competing
online service. Again, despite
no change in operating fundamentals,
the company sold off because
of a perceived threat and
negative market sentiment.
This was a classic "don't
fight the tape" story and
we finally sold the stock
because it failed to perform
for us.
Another
example was Carreker Corp.
(CANI), which provides payments
related software and solutions
to financial institutions.
The company basically helps
financial institutions improve
operational efficiency in
payments processing. The company
lowered guidance due to a
delay in a contract and was
subsequently sold due to fundamental
concerns.
|